Opioid crisis trims U.S. life expectancy, boosts hepatitis C: CDC

CHICAGO (Reuters) – The opioid crisis is rippling through the U.S. healthcare system, causing a spike in rates of hepatitis C related to increased opioid injections and reducing overall life expectancy among Americans, which has fallen for the second year in a row, U.S. health officials said on Thursday.


Source: Reuters Medical News

Revance will wait to seek backing for Botox-rival

(Reuters) – Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview.


Source: Reuters Medical News